Orthofix Medical Inc.
OFIX
$9.87
$0.181.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 825.37M | 822.31M | 818.06M | 809.03M | 804.53M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 825.37M | 822.31M | 818.06M | 809.03M | 804.53M |
| Cost of Revenue | 244.87M | 251.03M | 247.79M | 252.23M | 252.52M |
| Gross Profit | 580.51M | 571.28M | 570.27M | 556.80M | 552.01M |
| SG&A Expenses | 556.46M | 554.63M | 554.36M | 536.39M | 534.12M |
| Depreciation & Amortization | 13.06M | 14.31M | 15.59M | 17.02M | 17.47M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 875.78M | 885.82M | 887.02M | 877.45M | 878.02M |
| Operating Income | -50.41M | -63.50M | -68.96M | -68.42M | -73.49M |
| Income Before Tax | -59.51M | -90.81M | -118.33M | -122.70M | -140.84M |
| Income Tax Expenses | 495.00K | 1.38M | 788.00K | 1.01M | 2.23M |
| Earnings from Continuing Operations | -60.01 | -92.19 | -119.12 | -123.71 | -143.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.01M | -92.19M | -119.12M | -123.71M | -143.07M |
| EBIT | -50.41M | -63.50M | -68.96M | -68.42M | -73.49M |
| EBITDA | 12.95M | 662.00K | 7.45M | 9.02M | 1.49M |
| EPS Basic | -1.50 | -2.34 | -3.04 | -3.18 | -3.70 |
| Normalized Basic EPS | -0.98 | -1.15 | -1.49 | -1.53 | -1.78 |
| EPS Diluted | -1.51 | -2.35 | -3.04 | -3.18 | -3.70 |
| Normalized Diluted EPS | -0.98 | -1.15 | -1.49 | -1.53 | -1.78 |
| Average Basic Shares Outstanding | 159.72M | 158.46M | 157.16M | 155.88M | 154.40M |
| Average Diluted Shares Outstanding | 159.72M | 158.46M | 157.16M | 155.88M | 154.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |